Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,848,512
+$46,062 QoQ
Shares Held
11,795
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#450
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARSONS CAPITAL MANAGEMENT INC/RI holds $115,012,462 across 11 Drug Manufacturers - General names. NVS ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,385 | $31,646,963 | |
| 2 | JNJ |
Johnson & Johnson
|
103,244 | $26,220,878 | |
| 3 | ABBV |
AbbVie Inc.
|
99,302 | $24,988,355 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,146 | $12,097,761 | |
| 5 | AMGN |
Amgen Inc
|
23,390 | $8,469,986 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
82,435 | $4,749,904 | |
| 7 | PFE |
Pfizer Inc
|
145,818 | $3,511,297 | |
| 8 | NVS |
Novartis AG
This page
|
11,795 | $1,848,512 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,848,512 | 11,795 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,802,450 | 11,800 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,898,056 | 13,767 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,765,480 | 13,767 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,673,931 | 13,833 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,545,112 | 13,860 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,336,844 | 13,738 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,704,136 | 14,816 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,597,006 | 15,001 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,556,869 | 16,095 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,727,495 | 17,109 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,835,924 | 18,024 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,823,342 | 18,069 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,644,960 | 17,880 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,009,992 | 22,156 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,751,726 | 23,046 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,215,953 | 26,215 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,393,644 | 27,278 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $2,413,384 | 27,591 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $2,145,743 | 26,238 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,712,656 | 29,731 | Shares | Defined | 2021-08-03 | |
| 2021-03-31 | $2,326,423 | 27,216 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $2,797,110 | 29,621 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,377,747 | 27,343 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $2,569,891 | 29,424 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $2,240,248 | 27,171 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||